Replies to post #222645 on Biotech Values

[DewDiligence]

RVNC—Earlier this year I decided there was no reason to own Revance because of the time it was going to take to file. I wasn't wrong to sit most of the year out.

My viewpoint is long-term—i.e. several years. I don’t try to be too smart with the timing of additions and subtractions to my position, because stuff often happens when people least expect it. The average cost of my RVNC position is $15.

I’ve owned ENTA for 5.5 years and it’s been close to a 5-bagger. I see no reason why, in due course, the same can’t happen with RVNC.

[jmkobers]

<<Again I'm back to square one, why own the stock now. >>

Bogger, you don't see upside from here, @25???? Seems low to me based on what they got for China alone and considering the stellar trial results